申请人:Ribon Therapeutics Inc.
公开号:US20190194174A1
公开(公告)日:2019-06-27
The present invention relates to quinazolinones and related compounds which are inhibitors of PARP14 and are useful, for example, in the treatment of cancer and inflammatory diseases.
本发明涉及
喹唑啉酮和相关化合物,它们是PARP14的
抑制剂,例如在癌症和炎症性疾病的治疗中是有用的。